Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.
Press releases published on June 30, 2025
374Water Provides Update for Deployment of AirSCWO Technology at Orange County, California Sanitation District
GlobeNewswire
·
June 30, 2025
AirSCWO 6 System Fully Manufactured and Undergoing Factory Acceptance Testing DURHAM, N.C., June 30, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) (“374Water”) (the “Company”), a global leader in organic waste destruction technology for the …
Orangekloud Signs MOU for Development of Specialized LLM for Software Engineering and Application Development
GlobeNewswire
·
June 30, 2025
SINGAPORE, June 30, 2025 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (Nasdaq: ORKT) (“Orangekloud” or “the Company”), a Singapore-based technology company offering the eMOBIQ® No-Code platform for development of mobile applications, today announced the …
TruGolf Announces Portable Launch Monitor, LaunchBox, Available Globally on July 1st
GlobeNewswire
·
June 30, 2025
This new portable Launch Monitor by TruGolf is simple to use, compatible with PC and iOS Devices, and utilizes advanced hyper-speed camera technology to measure ball data inside and outdoors. Salt Lake City, Utah, June 30, 2025 (GLOBE NEWSWIRE) -- TruGolf …
Ashvattha Therapeutics Presents Positive Interim Phase 2 Results for Subcutaneous Migaldendranib Treatment for DME and Wet-AMD at 2025 MaculArt Meeting
GlobeNewswire
·
June 30, 2025
Monthly subcutaneous migaldendranib shows favorable safety with sustained efficacy through 24 weeks in patients with DME and wet-AMD Novel subcutaneous delivery may offer a more patient-friendly alternative to intravitreal injections, with the potential to …
Kneat Announces Upcoming Change to its Senior Leadership
GlobeNewswire
·
June 30, 2025
LIMERICK, Ireland, June 30, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, announces a change to its senior leadership team. Hugh Kavanagh, our CFO, is retiring …
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation
GlobeNewswire
·
June 30, 2025
SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a genetics-led consumer healthcare company, today announced that it has received approval from the U.S. Bankruptcy Court for the Eastern …
Bonx raises $8.6 million to champion European manufacturing with market-leading AI ERP
GlobeNewswire
·
June 30, 2025
Paris, June 30, 2025 (GLOBE NEWSWIRE) -- Europe’s manufacturing sector is under pressure. Mid-sized factories - long the engine of the continent’s economy - are being pulled in two directions: on one hand, rising global competition and supply chain …
LogicFlo raises $2.7M to arm every life sciences expert with their own AI workforce
GlobeNewswire
·
June 30, 2025
Boston, June 30, 2025 (GLOBE NEWSWIRE) -- Across life sciences, the brightest minds are buried in busywork. Regulatory strategists, medical writers, quality and safety experts - people trained to bring therapies to market - are still spending most of their …
Richtech Robotics Joint Venture Partner Secures $4M Sales Agreement to Expand Reach in Asia’s AI Robotics Market
GlobeNewswire
·
June 30, 2025
Agreement with Beijing Tongchuang Technology Development Co., Ltd. strengthens regional momentum through purchase, service, and licensing of flagship products LAS VEGAS, June 30, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech …
NV5 Awarded $20 Million in New York City Park Facilities Design and Construction Management Contracts
GlobeNewswire
·
June 30, 2025
HOLLYWOOD, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- NV5, a provider of technology, certification, and consulting solutions, announced today that it has been awarded over $20 million in engineering design and construction management contracts by the New York …
Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions
GlobeNewswire
·
June 30, 2025
RIYADH, Saudi Arabia and ISTANBUL and OXFORDSHIRE, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced that they have been appointed by …
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179
GlobeNewswire
·
June 30, 2025
– Study will evaluate safety and antiviral activity of ABI-1179 in participants with recurrent genital herpes – – ABI-1179 IND cleared to support study expansion to sites in United States – – Phase 1b studies for ABI-1179 and ABI-5366 running concurrently …
IMUNON Submits Plan in Consultation with the Exchange to Ensure Compliance with Nasdaq’s Listing Requirement, Anticipates Additional Compliance Period
GlobeNewswire
·
June 30, 2025
LAWRENCEVILLE, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that, in consultation with The Nasdaq Stock Market LLC (Nasdaq), it has …
SPR Receives Fourth Consecutive Northeast Ohio Top Workplaces Award
GlobeNewswire
·
June 30, 2025
- Based on employee feedback highlighting strong corporate culture - CLEVELAND, June 30, 2025 (GLOBE NEWSWIRE) -- For the fourth year in a row, SPR has been recognized as a Top Workplace by Northeast Ohio Top Workplaces. This recognition is based solely on …
Tilde Sciences Announces Availability Of VECAMYL™ (Mecamylamine) With Exclusive Distribution Through Optime Care Specialty Pharmacy
GlobeNewswire
·
June 30, 2025
JERSEY CITY, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- Tilde Sciences LLC (“Tilde”), a U.S.–based biopharmaceutical company dedicated to developing therapies for rare diseases with significant unmet need, today announced the nationwide availability of …
Tectonic Therapeutic Joins Russell 3000® Index
GlobeNewswire
·
June 30, 2025
WATERTOWN, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of …
Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors with Ivonescimab in RAS Mutant Tumors
GlobeNewswire
·
June 30, 2025
REDWOOD CITY, Calif. and MIAMI, June 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers and Summit Therapeutics, Inc. (Nasdaq: …
Spectral AI Announces Submission to FDA of its DeepView® System
GlobeNewswire
·
June 30, 2025
DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 …
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
GlobeNewswire
·
June 30, 2025
SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its addition to the Russell 2000® …
Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live’25
GlobeNewswire
·
June 30, 2025
SPRING Trial Data Presented at BSG Live’25 Confirms the Clinical Potential of Nebokitug as a First-in-Class Novel Treatment for PSC and Supports Advancement to Phase 3 Treatment with Nebokitug Is Well-Tolerated and Associated with Substantial Improvements …